At a glance

Type

Peptide / related clinical research

Regulatory context

The cited source describes research, not a determination of present marketing authorisation. Country, formulation and indication must be checked separately.

Evidence

Published reports concern specific anxiety populations and short-term outcomes. Small samples and incompletely reported study methods restrict certainty about benefit and safety.

What it is

Selank is a synthetic neuroactive peptide investigated for anxiety-related effects. A mechanistic study examined enkephalin breakdown, but a laboratory mechanism cannot by itself establish a clinical treatment effect. Different salts, preparations and routes must not be assumed equivalent. [1]

What the anxiety studies measured

A 2008 comparative report enrolled 62 people with generalised anxiety disorder or neurasthenia: 30 received Selank and 32 medazepam. The authors reported similar anxiety-score improvements. The indexed record classifies it as a randomised trial, but the available abstract gives limited detail on masking, allocation and effect estimates. It is not a modern demonstration of clinical equivalence. [2]

A second comparative report

A 2014 study compared Selank and phenazepam in 60 patients with anxiety-related or somatoform disorders. The authors reported improvements in anxiety and quality of life. The abstract does not establish a sufficiently detailed blinded, placebo-controlled design to rule out expectancy and other biases, or provide a robust long-term safety estimate. [3]

What brain imaging adds

The 2020 study involving Selank, Semax and placebo in 52 healthy volunteers measured resting-state brain connectivity shortly after exposure. This is a mechanistic endpoint. It does not show lasting relief of an anxiety disorder or improved everyday cognition. [4]

What remains uncertain

Small positive reports can motivate better trials without establishing routine care. Their results should not be presented as proof that Selank replaces psychological therapy or established medicines, prevents dependence, or is free of adverse effects. Interactions and evidence for the exact preparation need separate consideration. [2] [3] [5]

Questions for your doctor

What diagnosis is being treated and how will improvement be measured? Which established options have stronger evidence? Discuss current medicines and any changes with the treating clinician; a research summary is not a reason to stop prescribed anxiety treatment. [2] [3]

Safety and clinical context

FDA identifies limited safety information and potential immunogenicity concerns for Selank acetate. Long-term safety and medicine interactions remain important uncertainties. [5]

Evidence and authorisation depend on the product, formulation, indication and country. US labelling does not establish Thai authorisation. This guide is educational and is not a dosing or self-treatment protocol.